EPISODE · Aug 14, 2026 · 7 MIN
SHTG Digest — Friday August 14, 2026
from SHTG Daily Digest — Weiss Lab
A quiet cycle on both fronts — the only qualifying PubMed hit is a JAMA news synopsis recapping June's Tryngolza approval rather than new primary research, and no fresh trade-press stories on SHTG, Arrowhead, Alnylam, or Ionis cleared the 5-day/dedup bar, with the field's most consequential items (Arrowhead's SHASTA-3/4 topline and Alnylam's Amvuttra-driven selloff) already covered in a recent episode.
Embed this episode
Ready to play
SHTG Digest — Friday August 14, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.